157 related articles for article (PubMed ID: 15907788)
1. Beta-lactam antibiotics are multipotent agents to combat neurological diseases.
Ji HF; Shen L; Zhang HY
Biochem Biophys Res Commun; 2005 Aug; 333(3):661-3. PubMed ID: 15907788
[TBL] [Abstract][Full Text] [Related]
2. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.
Rothstein JD; Patel S; Regan MR; Haenggeli C; Huang YH; Bergles DE; Jin L; Dykes Hoberg M; Vidensky S; Chung DS; Toan SV; Bruijn LI; Su ZZ; Gupta P; Fisher PB
Nature; 2005 Jan; 433(7021):73-7. PubMed ID: 15635412
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics acting as neuroprotectants via mechanisms independent of their anti-infective activities.
Stock ML; Fiedler KJ; Acharya S; Lange JK; Mlynarczyk GS; Anderson SJ; McCormack GR; Kanuri SH; Kondru NC; Brewer MT; Carlson SA
Neuropharmacology; 2013 Oct; 73():174-82. PubMed ID: 23748053
[TBL] [Abstract][Full Text] [Related]
4. Beta-lactam antibiotic resistance: a current structural perspective.
Wilke MS; Lovering AL; Strynadka NC
Curr Opin Microbiol; 2005 Oct; 8(5):525-33. PubMed ID: 16129657
[TBL] [Abstract][Full Text] [Related]
5. Surprise neuroprotective potential of beta-lactam antibiotics.
Senior K
Drug Discov Today; 2005 Mar; 10(5):300. PubMed ID: 15749274
[No Abstract] [Full Text] [Related]
6. New ideas for therapy in ALS: critical considerations.
Beghi E; Bendotti C; Mennini T
Amyotroph Lateral Scler; 2006 Jun; 7(2):126-7; discussion 127. PubMed ID: 16753979
[No Abstract] [Full Text] [Related]
7. [Beta-lactam antibiotics].
Suárez C; Gudiol F
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):116-29. PubMed ID: 19254642
[TBL] [Abstract][Full Text] [Related]
8. Insights into the reaction of beta-lactam antibiotics with copper(II) ions in aqueous and micellar media: kinetic and spectrometric studies.
Fernández-González A; Badía R; Díaz-García ME
Anal Biochem; 2005 Jun; 341(1):113-21. PubMed ID: 15866535
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics that protect the brain.
Secko D
CMAJ; 2005 Feb; 172(4):467-8. PubMed ID: 15710934
[No Abstract] [Full Text] [Related]
10. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
11. The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke.
Thöne-Reineke C; Neumann C; Namsolleck P; Schmerbach K; Krikov M; Schefe JH; Lucht K; Hörtnagl H; Godes M; Müller S; Rumschüssel K; Funke-Kaiser H; Villringer A; Steckelings UM; Unger T
J Hypertens; 2008 Dec; 26(12):2426-35. PubMed ID: 19008722
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactam antibiotics prevent Salmonella-mediated bovine encephalopathy regardless of the β-lactam resistance status of the bacteria.
Xiong N; Brewer MT; Anderson KL; Watrous GK; Weeks KE; Barnhill AE; Day TA; Kimber MJ; Carlson SA
Vet J; 2012 Jun; 192(3):535-7. PubMed ID: 21798771
[TBL] [Abstract][Full Text] [Related]
13. Role of GLT-1 transporter activation in prevention of cannabinoid tolerance by the β-lactam antibiotic, ceftriaxone, in mice.
Gunduz O; Oltulu C; Ulugol A
Pharmacol Biochem Behav; 2011 Jul; 99(1):100-3. PubMed ID: 21536061
[TBL] [Abstract][Full Text] [Related]
14. Part II. Introduction to the beta-lactam antibiotics.
Cooper TW; Gibbs WJ; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2006 Oct; 99(10):516-20. PubMed ID: 17125105
[No Abstract] [Full Text] [Related]
15. Mechanisms of resistance to beta-lactams in some common Gram-negative bacteria causing nosocomial infections.
Suárez CJ; Lolans K; Villegas MV; Quinn JP
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):915-22. PubMed ID: 16307504
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC
J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241
[TBL] [Abstract][Full Text] [Related]
17. Part V. Other beta-lactam antimicrobials.
Gibbs WJ; Cooper TW; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2007 Jan; 100(1):23-5. PubMed ID: 17378498
[No Abstract] [Full Text] [Related]
18. New career possibilities for certain antibiotics?
Eisenstein M
Lab Anim (NY); 2005 Feb; 34(2):10. PubMed ID: 15685178
[No Abstract] [Full Text] [Related]
19. Differential effects of beta-lactams on human IFN-gamma activity.
Brooks BM; Hart CA; Coleman JW
J Antimicrob Chemother; 2005 Dec; 56(6):1122-5. PubMed ID: 16239287
[TBL] [Abstract][Full Text] [Related]
20. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
